MAPK-ERK2, a downstream target of the Ras signaling implicated in NF1-MPNST pathogenesis, is reported to regulate UBR5 function in cellular signaling through phosphorylation [83,84]. The gene discussed is UBR5; the disease is malignant peripheral nerve sheath tumor.